News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Elastin Biosciences Announces a Significant Breakthrough in the Restoration of Elastin, Opening New Avenues for Treating Elastin-Deficiency Disorders
Saturday, September 02, 2023Longaevus Technologies is excited to announce the establishment of Elastin Biosciences as an independent entity following the remarkable preclinical results achieved by three of its research programs
First Patient With Chronic Hepatitis B Receives Initial Dose of ISA104 in Phase 1 Clinical Study
Friday, September 01, 2023ISA Pharmaceuticals BV a clinicalstage biotech firm dedicated to developing novel immunotherapies for cancer and serious infectious diseases has announced the initiation of the HEBPEP study
Ai Therapeutics Initiates Phase 2 Clinical Trial to Evaluate LAM-001 for Pulmonary Arterial Hypertension (PAH) Treatment
Friday, September 01, 2023AI Therapeutics a clinicalstage biopharmaceutical company specializing in rare disease therapeutics has unveiled the initiation of a Phase study for LAM its innovative inhaled form of sirolimus This development aims to address pulmonary arterial hyp...
Relief Therapeutics and Acer Therapeutics Forge Exclusive License Agreement for OLPRUVA™ (ACER-001)
Thursday, August 31, 2023RELIEF THERAPEUTICS Holding SA SWXRLF has recently entered into an exclusive licensing agreement with Acer Therapeutics Inc for the development and commercialization of OLPRUVA sodium phenylbutyrate
European Commission Grants Approval to Roche's Evrysdi for Infants Under Two Months Old With Spinal Muscular Atrophy (SMA)
Wednesday, August 30, 2023Roche SIX RO ROG OTCQX RHHBY has received approval from the European Commission to expand the use of Evrysdi risdiplam within the European Union EU
Laurent Pharmaceuticals Receives Approval From Health Canada to Commence Phase 2/3 Clinical Trial for Long COVID
Wednesday, August 30, 2023Laurent Pharmaceuticals Inc headquartered in Montreal has received approval from Health Canada to initiate the ESSOR trial a Phase randomized placebocontrolled study
Cantex Pharmaceuticals Initiates Investigator-initiated Phase 2 Clinical Trial to Study Azeliragon Combined with Stereotactic Radiosurgery for Brain Metastases Treatment
Tuesday, August 29, 2023Cantex Pharmaceuticals a clinicalstage pharmaceutical company focused on developing innovative therapies for cancer and lifethreatening conditions has announced the initiation of a Phase clinical trial
Sandoz Successfully Concludes Acquisition of Leading Antifungal Agent Mycamine® From Astellas, Further Strengthening Global Anti-infectives Portfolio
Monday, August 28, 2023Sandoz a major player in the field of generic and biosimilar medicines has successfully concluded the acquisition of the global brand rights for Mycamine micafungin sodium a leading systemic antifungal agent This acquisition was made from Astellas
Ceapro and Symrise Prolong Exclusive Global Supply and Distribution Agreement for Active Ingredients
Saturday, August 26, 2023Ceapro Inc publicly traded as CZO on TSXV and as CRPOF on OTCQX a burgeoning biotechnology enterprise specializing in the development and commercialization of active ingredients for the healthcare and cosmetic sectors has announced a significant amen...
Alentis Therapeutics Receives FDA Fast Track Designation for ALE.C04 in Treatment of Claudin-1 Positive HNSCC
Friday, August 25, 2023Alentis Therapeutics a clinicalstage biotechnology company has been granted Fast Track development status by the US Food and Drug Administration FDA for their drug candidate ALEC This drug is being developed to treat patients with recurrent or metast...
